Managing Metabolic Dysfunction-Associated Steatotic Liver Disease
Tracking # 20-1293500
Course overview
This course equips healthcare providers with the latest insights into metabolic dysfunction-associated steatotic liver disease (MASLD). It covers the etiology, pathophysiology, and updated classifications of MASLD and its progression to more severe conditions like MASH, cirrhosis, and hepatocellular carcinoma. Participants will learn evidence-based screening and diagnostic practices, including the use of noninvasive tools, and explore comprehensive management strategies focusing on lifestyle interventions, pharmacotherapy, and interprofessional collaboration. Special emphasis is placed on understanding the impact of comorbidities. The goal of this course is to provide the healthcare team with the newest guidelines for managing MASLD.
Subject areas
This course counts toward the state boards and subject areas below.